- Home
- IMMX vs CLW Comparison
IMMX vs CLW Comparison
Compare IMMX & CLW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | IMMX | CLW |
|---|---|---|
| Founded | 2014 | 2005 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medicinal Chemicals and Botanical Products | Paper |
| Sector | Health Care | Basic Materials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 300.9M | 282.8M |
| IPO Year | 2021 | N/A |
Fundamental Metrics
Financial Performance| Metric | IMMX | CLW |
|---|---|---|
| Price | $5.67 | $18.48 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 2 |
| Target Price | $12.00 | ★ $30.00 |
| AVG Volume (30 Days) | ★ 1.3M | 200.1K |
| Earning Date | 11-07-2025 | 10-28-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 875.72 |
| EPS | N/A | ★ 8.63 |
| Revenue | N/A | ★ $1,556,100,000.00 |
| Revenue This Year | N/A | $13.91 |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $2.09 |
| Revenue Growth | N/A | ★ 23.00 |
| 52 Week Low | $1.34 | $16.44 |
| 52 Week High | $7.73 | $33.57 |
Technical Indicators
Market Signals| Indicator | IMMX | CLW |
|---|---|---|
| Relative Strength Index (RSI) | 56.92 | 54.46 |
| Support Level | $5.33 | $17.49 |
| Resistance Level | $7.73 | $19.07 |
| Average True Range (ATR) | 0.77 | 0.63 |
| MACD | -0.07 | 0.14 |
| Stochastic Oscillator | 48.35 | 66.96 |
Price Performance
Historical ComparisonAbout IMMX Immix Biopharma Inc.
Immix Biopharma Inc is engaged in the discovery and development of novel cell therapies for hematologic malignancies (blood cancers) and other indications. It is a clinical-stage biopharmaceutical company developing a novel class of Tissue-Specific Therapeutics TM in oncology and inflammation. Its TME Normalization Technology allows drug candidates to circulate in the bloodstream, exit through tumor blood vessels and simultaneously attack all components of the TME. Its product candidates include CAR-T NXC-201 for autoimmune diseases, and IMX-110 for treatment of soft tissue sarcoma.
About CLW Clearwater Paper Corporation
Clearwater Paper Corp is engaged in the manufacturing and supplier of Solid Bleached Sulfate (SBS) paperboard packaging products. The company products includes: SBS paperboard which is a premium paperboard grade that is frequently used to produce folding cartons, food service, commercial printing items. It generates maximum revenue from Pulp and Paperboard segment. Company operate in United States and have globalized access too. Geographically, it derives maximum revenue from the United States.